Skip to main content
CBUS logo
CBUS
(NASDAQ)
Cibus, Inc.
$1.36-- (--)
Loading... - Market loading

Cibus (CBUS) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Cibus, Inc.
CBUSNasdaq Stock MarketHealthcareBiotechnology

About Cibus

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Company Information

CEOCraig Wichner
Founded2010
IPO DateJuly 20, 2017
Employees118
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock
Share ClassClass A Shares

Contact Information

Phone858 450 0008
Address
6455 Nancy Ridge Drive San Diego, California 92121 United States

Corporate Identifiers

CIK0001705843
CUSIP17166A101
ISINUS17166A1016
EIN27-1967997
SIC2870

Leadership Team & Key Executives

Dr. Peter R. Beetham B.Sc., Ph.D.
Co-Founder, Interim Chief Executive Officer, President, Chief Operating Officer and Director
Dr. Gregory F. Gocal Ph.D.
Co-Founder, Chief Scientific Officer and Executive Vice President
Rory Balfour Riggs M.B.A.
Co-Founder and Director
Jason Stokes Esq., J.D.
Chief Administrative Officer, General Counsel and Corporate Secretary
Cornelis Broos M.Sc.
Chief Financial Officer
Rosa Cheuk Kim J.D.
Senior Vice President of Legal
Dr. Noel Sauer Ph.D.
Senior Vice President of Research